CJC-1295 Side Effects
CJC-1295 is a GHRH analog usually stacked with ipamorelin. Its side-effect profile is the standard GH-axis set: injection-site reactions, mild fluid retention, and effects tied to rising IGF-1.
When they appear & how long they last
Effects relate to the GH-axis response building over the first weeks. The DAC vs no-DAC form changes the dosing cadence but not the core side-effect set.
Commonly reported CJC-1295 side effects
Redness or irritation at the SC site.
Brief, shortly after injection.
Mild fluid retention from the GH-axis effect.
From mild fluid retention - carpal-tunnel-like.
Sleep-architecture changes as GH pulses shift.
When to contact your provider
- Persistent swelling or fluid retention
- Fasting glucose trending out of range
- Numbness/tingling that does not resolve
- Allergic-reaction signs
Biomarkers worth tracking on CJC-1295
These catch issues early - before you feel them. Pull a baseline before you start, then re-check on the cadence noted below.
Primary GH-axis marker - confirm an in-range response at ~6 weeks.
Watch for GH-driven glucose drift.
How to actually track CJC-1295 side effects
CJC-1295 + ipamorelin is the canonical GH-peptide stack - track the pair against a single IGF-1 timeline. The DAC form means a non-daily schedule, so a dose log earns its keep. Note sleep quality and any fluid retention against the dose; swelling usually flags the upper edge of your tolerance.
Track CJC-1295 with MyProtocolStack →